Cumberland Pharmaceuticals (CPIX) EPS (Basic) Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.41 Mn | 112.54 Mn | - | -480.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151.64% |
| Mar 31, 2026 | -351.35% |
| Dec 31, 2025 | 29.55% |
| Sep 30, 2025 | -19.13% |
| Jun 30, 2025 | 37.08% |
| Mar 31, 2025 | 161.90% |
| Dec 31, 2024 | 69.31% |
| Sep 30, 2024 | -46.87% |
| Jun 30, 2024 | -230.39% |
| Mar 31, 2024 | -1,224.72% |
| Dec 31, 2021 | -41.29% |
| Sep 30, 2021 | -35.05% |
| Jun 30, 2021 | -31.27% |
| Mar 31, 2021 | -38.38% |
| Dec 31, 2020 | -63.06% |
| Sep 30, 2020 | -41.46% |
| Jun 30, 2020 | -2.52% |
| Mar 31, 2020 | -27.58% |
| Dec 31, 2019 | 140.39% |
| Sep 30, 2019 | 182.17% |